Appointment Deepens Financial and Operational Expertise of Boardas Company Approaches Potential CommercializationSOUTH SAN FRANCISCO, Calif., ...

January 29, 2025 • Robert F. Kennedy Jr. faced senators today in a contentious confirmation hearing to serve as Health and Human Services Secretary under President Trump. He's a former Democrat ...

Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of ...

Health care is the discipline concerned with the provision and delivery of health services to a patient population by personnel in professional and allied health occupations. We developed a ...

View Our Latest Stock Analysis on CYTK Cytokinetics Stock Performance CYTK opened at $49.94 on Tuesday. The company has a current ratio of 9.28, a quick ratio of 9.28 and a debt-to-equity ratio of ...

Cytokinetics Price Performance Shares of NASDAQ:CYTK opened at $49.94 on Tuesday. The company has a market cap of $5.89 billion, a P/E ratio of -9.28 and a beta of 0.82. The business has a fifty ...

In this article, we are going to take a look at where Cytokinetics, Incorporated (NASDAQ:CYTK) stands against other stocks that analysts are talking about. Like any other informed investor ...

Shares of Cytokinetics CYTK gained 2.2% on Wednesday after the company began enrolling patients in its mid-stage study of CK-4021586 (CK-586), a cardiac myosin inhibitor, for treating heart ...

A health care company executive from Valley Stream has been indicted on child pornography charges and remanded to a federal jail Wednesday. Jacob Walden, 38, pleaded not guilty to a six-count ...

Cytokinetics' aficamten shows strong potential in the $3B U.S. oHCM market, despite competition from Bristol Myers’ Camzyos. Stifel sets a $80 price target, highlighting catalysts expected over ...

Cytokinetics has fallen out of favor with investors after a turbulent start to 2024, marked by a controversial Royalty Pharma Plc (NASDAQ:RPRX) deal and no mergers or acquisitions. Investors ...